Comment on: The Gabrin sign

Affiliations

¹ Center for Dermatology and Hair Diseases Professor Trüeb and University of Zurich, Switzerland. Electronic address: r.trueeb@derma-haarcenter.ch.
² Skinterface, Hair Clinic, Tournai and Brussels, Belgium.
³ Department of Dermatology, Universidade Federal Fluminense, Centro de Ciências Médicas, Hospital Universitário Antonia Pedro, Niterói-Rio de Janeiro Brazil.
⁴ Department of Dermatology, Medical University, Graz, Austria.
⁵ Department of Dermatology, Yonsei University, Wonju College of Medicine, Gangwon-do, Republic of Korea.
⁶ 1st Department of Dermatology-Venereology, Aristotle University Medical School, Hospital of Skin and Venereal Diseases, Thessaloniki, Greece.
⁷ Department of Dermatology, Alvaro Alvim School Hospital, Campos dos Goytacazes, Rio de Janeiro, Brazil.
⁸ Center for Dermatology and Hair Diseases Professor Trüeb and University of Zurich, Switzerland.

Comment

Ralph M Trüeb et al. J Am Acad Dermatol. 2021 Mar.

. 2021 Mar;84(3):e147-e148.

doi: 10.1016/j.jaad.2020.11.046. Epub 2020 Nov 27.

¹ Center for Dermatology and Hair Diseases Professor Trüeb and University of Zurich, Switzerland. Electronic address: r.trueeb@derma-haarcenter.ch.
² Skinterface, Hair Clinic, Tournai and Brussels, Belgium.
³ Department of Dermatology, Universidade Federal Fluminense, Centro de Ciências Médicas, Hospital Universitário Antonia Pedro, Niterói-Rio de Janeiro Brazil.
⁴ Department of Dermatology, Medical University, Graz, Austria.
⁵ Department of Dermatology, Yonsei University, Wonju College of Medicine, Gangwon-do, Republic of Korea.
⁶ 1st Department of Dermatology-Venereology, Aristotle University Medical School, Hospital of Skin and Venereal Diseases, Thessaloniki, Greece.
⁷ Department of Dermatology, Alvaro Alvim School Hospital, Campos dos Goytacazes, Rio de Janeiro, Brazil.
⁸ Center for Dermatology and Hair Diseases Professor Trüeb and University of Zurich, Switzerland.

No abstract available

Conflict of interest statement

Conflicts of interest None disclosed.

Reply to comment on: The Gabrin sign.
Wambier CG, Vaño-Galván S, Goren A. Wambier CG, et al. J Am Acad Dermatol. 2021 Mar;84(3):e149-e150. doi: 10.1016/j.jaad.2020.11.045. Epub 2020 Nov 27. J Am Acad Dermatol. 2021. PMID: 33253847 Free PMC article. No abstract available.

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".
Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Fonda-Pascual P, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A. Wambier CG, et al. J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22. J Am Acad Dermatol. 2020. PMID: 32446821 Free PMC article.

1. Wambier C.G., Vaño-Galván S., McCoy J., et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the “Gabrin sign”. J Am Acad Dermatol. 2020;83(2):680–682. - PMC - PubMed
1. Kroumpouzos G. Effects of 5-alpha reductase inhibitors on lung function: a reason for discontinuation during COVID-19 pandemic? Dermatol Ther. 2020;33(4):e13535. - PMC - PubMed
1. Nanes B.A. Androgenetic alopecia in COVID-19: compared to what? J Am Acad Dermatol. 2020;83(6):e451. - PMC - PubMed
1. Bukovac D., Makše U. Comment on Androgenetic alopecia present in the majority of patients hospitalized with COVID-19. J Am Acad Dermatol. 2020;84(1):e51–e52. - PMC - PubMed
1. van der Made C.I., Simons A., Schuurs-Hoeijmakers J., et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324(7):663–673. - PMC - PubMed